Research Article

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma

Figure 8

Therapeutic efficacy of EGFR-specific CAR-NK-92 cells combined with cabozantinib for human renal cancer xenografts established with 786-O cells. (a) Schematic diagram showing the treatment program of the mice. (b) The tumor growth curves during the experiment. (c) Luminescence images showing the tumor size at the end of the treatment. (d) Quantitative results of the tumor luminescence intensity shown in (c). ; ; .
(a)
(b)
(c)
(d)